This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

N-terminal propeptide of procollagen type III (PIIINP) and methotrexate

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

In patients with psoriasis on methotrexate, measurement of procollagen III N-terminal peptide is advised as an indicator of hepatic fibrosis, although this is usually performed in secondarycare (1,2)

What is procollagen III N-terminal peptide?

  • process of liver fibrosis is assumed to be caused by the excess production of extracellular matrix (ECM) in hepatic stellate cells (HSCs) (3,4)
  • the increase of ECM deposited fragments in the Disse's space leads to liver injury
    • largest component of the ECM is collagen
    • in the liver type III collagen mainly occurs
  • during the synthesis of type III collagen, the N-terminal propeptide of procollagen type III (PIIINP) is detached from procollagen type III
    • so the fibrogenesis results in release of ECM fragments into the blood
      • quantity of propeptide of procollagen type III can be a direct indicator of collagen synthesis and its deposition in the extracellular space
      • increased amount of propeptide of type III procollagen may indicate the transformation of normal liver tissue into connective tissue (1,2,3,4)

Notes (6):

  • PIIINP is not a liver-specific marker
    • increased concentrations of PIIINP have also been other conditions associated with abnormal production of collagen
      • for example congestive heart failure, hypertension, coronary heart disease and pulmonary fibrosis

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.